TABLE 3

Comparison of Sociodemographics, Clinical Variables, and Secondary Outcomes for Caregivers With a Discharge Medication–Related Failure

Failure (n = 110)No Failure (n = 47)P
Independent variables
 Age, y, median (IQR)3 (1.8 to 5.0)3 (1.2 to 7.0).93
 SES z score, median (IQR)a−3.5 (−7.0 to −1.6)−3.0 (−5.8 to −1.0).26
 LOS, d, median (IQR)1.9 (1.2 to 3.1)2.3 (1.7 to 3.2).06
 Sex of child, female, n (%)50 (46)26 (55).26
Race and/or ethnicity, n (%).03
 Hispanic41 (37)16 (34)
 Non-Hispanic African American43 (39)11 (23)
 Non-Hispanic other race13 (12)14 (30)
 Unavailable13 (12)6 (13)
Used hospital’s outpatient pharmacy, n (%)60 (55)28 (60).56
No. eligible medications, n (%)b.28
 180 (73)38 (81)
 223 (21)5 (11)
 ≥37 (6)4 (8)
Class of medication, n (%)b.79
 Steroid37 (34)13 (28)
 Antibiotic or antifungal44 (40)23 (49)
 Antiviral17 (15)6 (13)
 Other12 (11)5 (10)
APR-DRG of hospitalization, n (%)b.47
 Asthma34 (31)11 (23)
 Respiratory tract infection38 (35)13 (28)
 Gastrointestinal problem7 (6)3 (6)
 Genitourinary problem3 (3)4 (9)
 Skin and soft-tissue infection6 (5)3 (6)
 Other22 (20)13 (28)
Weekend discharge, n (%)41 (37)14 (30).37
Secondary outcomes, n (%)
 AVS missing information88 (82)36 (77).49
 Discrepant chartb3 (3)5 (11).06
 Complex dosing24 (22)15 (32).18
  • Total sample size: SES: 106 failures and 45 no failure; discrepant chart: 106 failures and 46 no failure; AVS missing information: 108 failures and 47 no failure. APR-DRG, All Patient Refined Diagnosis Related Group; IQR, interquartile range; LOS, length of stay; —, not applicable.

  • a SES was reported as a z score calculated from small census tract data based on the patient’s home address; it reveals the deviation from the mean of the New York State population.31

  • b Fisher’s exact test was used.